Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

DEAF1 activates KCNMA1. 4 / 4

| 4

➶

reach

"12 Furthermore, the NADase activity of SPN augments the cytotoxicity and the hemolytic activity of SLO."

28034602

➶

reach

"This result is consistent with a previous report that SPN augments SLO mediated hemolysis and cytotoxicity."

28034602

➶

reach

"Spn significantly enhances SLO-mediated cytotoxicity, but it also inactivates IL-1β ."

29691463

➶

reach

"Because the SPN deficient mutant produces SLO, the manipulation of membrane function can not solely be due to an effect of the cytolysin, but must also involve SPN."

11163247

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

DEAF1 activates KCNMA1. 4 / 4

Our Sources:

Databases

Reading